Skip to main content
. 2016 Sep 12;28(1):e7. doi: 10.3802/jgo.2017.28.e7

Table 3. Determinants of disease specific mortality.

Determinants Events/N Model 1 (unadjusted) Model 2 (age-adjusted) Model 3 (fully adjusted)
HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value
Age (per 10 yr) - 1.04 0.83, 1.30 0.742 - - - 1.08 0.83, 1.40 0.568
Decline in CA125 <0.001
<50%* 30/41 1.00 - - 1.00 - - 1.00 - -
50%–79% 22/42 0.59 0.34, 1.05 0.071 0.58 0.33, 1.02 0.059 0.52 0.28, 0.96 0.036
≥80% 15/40 0.35 0.19, 0.67 0.001 0.34 0.18, 0.65 0.001 0.26 0.13, 0.54 0.001
Histology
Other 26/40 1.00 - - 1.00 - - 1.00 - -
Serous 41/83 0.62 0.37, 1.02 0.062 0.61 0.37, 1.02 0.061 0.46 0.26, 0.81 0.007
Tumor grade 0.687
1 or 2 19/33 1.00 - - 1.00 - - 1.00 - -
3 33/65 0.96 0.53, 1.75 0.896 0.94 0.52, 1.72 0.851 1.11 0.59, 2.08 0.810
Unknown 15/25 0.85 0.43, 1.69 0.644 0.81 0.40, 1.66 0.568 1.01 0.53, 1.94 0.972
FIGO
IV 17/24 1.00 - - 1.00 - - 1.00 - -
III 49/89 0.71 0.40, 1.26 0.240 0.71 0.40, 1.25 0.236 1.01 0.53, 1.94 0.972
II 1/10 0.09 0.01, 0.72 0.022 0.09 0.01, 0.72 0.023 0.17 0.02, 1.44 0.104
Ascites 0.710
None 16/34 1.00 - - 1.00 - - 1.00 - -
0–1,000 10/27 0.80 0.35, 1.80 0.586 0.80 0.35, 1.81 0.792 0.75 0.32, 1.77 0.509
>1,000 34/51 1.41 0.76, 2.60 0.277 1.41 0.76, 2.60 0.277 1.33 0.67, 2.64 0.413
Unknown 7/11 1.10 0.45, 2.70 0.747 1.10 0.45, 2.60 0.828 0.81 0.31, 2.15 0.675
Extensive surgery
No 41/75 1.00 - - 1.00 - - 1.00 - -
Yes 26/48 0.98 0.59, 1.62 0.927 0.98 0.59, 1.62 0.924 0.80 0.47, 1.38 0.427
Surgery outcome
Inadequate 30/43 1.00 - - 1.00 - - 1.00 - -
Optimal 26/47 0.70 0.41, 1.20 0.201 0.72 0.42, 1.23 0.225 0.81 0.44, 1.50 0.509
Complete 11/33 0.35 0.17, 0.71 0.003 0.34 0.17, 0.69 0.003 0.52 0.23, 1.22 0.133

Model 1, crude (i.e. unadjusted); Model 2, adjusted for age; Model 3, fully adjusted model (i.e. model 2 + all determinants considered).

HR, hazard ratio (vs. referent category as indicated by HR=1.00); CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics.

*Includes 10 patients in whom no changes or slight increases in CA125 were observed between pre- and postoperative.